Compare H1B visa sponsorship data between Ernst & Young U.S. and SRI Srinivasa Pharma. See how they stack up on salary, approval rates, and more.

Key Statistics Comparison

Total H1B Filings
+1330775%
53,235
Ernst & Young U.S.
4
SRI Srinivasa Pharma
Median Salary
$148,000
Ernst & Young U.S.
+5.4%
$156,468
SRI Srinivasa Pharma
Approval Rate
100.0%
Ernst & Young U.S.
100.0%
SRI Srinivasa Pharma
Years Sponsoring
+500%
18
Ernst & Young U.S.
3
SRI Srinivasa Pharma

Historical Trends

H1B Filings Over Time

Ernst & Young U.S.
SRI Srinivasa Pharma
2008 2011 2014 2017 2020 2025 1 4,844 9,687

Median Salary Trend

Ernst & Young U.S.
SRI Srinivasa Pharma
2008 2011 2014 2017 2020 2025 $71k $127k $183k

Where & What They Hire

Top H1B Job Categories

Ernst & Young U.S.
Accountants and Auditors 580 filings
Database Administrators 449 filings
Software Developers 273 filings
Computer and Information Systems Managers 254 filings
Financial and Investment Analysts 185 filings
SRI Srinivasa Pharma
Pharmacists 1 filings

Top H1B Work Locations

Ernst & Young U.S.
New York, NY 275 filings
Chicago, IL 149 filings
San Francisco, CA 98 filings
Hoboken, NJ 97 filings
Dallas, TX 83 filings
SRI Srinivasa Pharma
Jersey City, NJ 1 filings

Year-by-Year Breakdown

Year Ernst & Young U.S. SRI Srinivasa Pharma
Filings Salary Approval Filings Salary Approval
FY2025 2,264 $148,000 100.0% 1 $156,468 100.0%
FY2024 1,379 $166,114 99.6% - - -
FY2023 1,447 $152,685 100.0% - - -
FY2022 1,856 $150,000 100.0% 2 $126,293 100.0%
FY2021 1,244 $125,000 99.9% - - -
FY2020 766 $117,000 100.0% - - -
FY2019 8,806 $115,000 99.3% 1 $90,522 100.0%
FY2018 6,961 $112,528 99.2% - - -
FY2017 6,140 $97,400 98.5% - - -
FY2016 5,338 $90,000 99.0% - - -
Showing most recent 10 years of 18 total

Frequently Asked Questions

Which company pays higher H1B salaries, Ernst & Young U.S. or SRI Srinivasa Pharma?
SRI Srinivasa Pharma pays higher H1B salaries with a median of $156,468 compared to Ernst & Young U.S.'s $148,000.
Which company sponsors more H1B visas, Ernst & Young U.S. or SRI Srinivasa Pharma?
Ernst & Young U.S. has sponsored more H1B visas with 53,235 total filings compared to SRI Srinivasa Pharma's 4.
How do Ernst & Young U.S. and SRI Srinivasa Pharma H1B approval rates compare?
Ernst & Young U.S. has a 100.0% H1B approval rate while SRI Srinivasa Pharma has 100.0%. Both companies have the same approval rate.

View Full Details